Drug carrier |
Spherical liposome |
Lenticular liposome |
Nanogel |
Micellar composite hydrogel |
Payload |
Eptifibatide[39]
|
Carboxyfluorescein for imaging[31]
|
Plasmalemma vesicle associated protein (PLVAP) antibody[58]
|
Simvastatin[71]
|
Drug target |
Thrombosis |
Constricted arteries with atherosclerosis |
PLVAP in lung cells |
Inflammatory macrophages at the thrombotic site |
Drug development phase |
Prevention of thrombotic occlusion in mice |
Delivery of an imaging dye in an in vitro arterial model |
Delivery of an antibody in mice |
Inhibition of thrombosis in mice and rabbits |
Carrier materials |
Phosphatidylcholine with Brij 76 |
1,3-dipalmitamidopropan-2-yl 2-(trimethylammonio)ethyl phosphate (Pad–PC–Pad) |
Lysozyme-dextran |
Hyaluronic acid (HA) modified with glycidyl methacrylate |
Carrier size |
200 nm |
100 nm |
150–300 nm |
Micelles: 100 nm |
Shear range of release |
> 1500 s−1
|
~40 Pa (2 Pa represents a healthy artery) |
> 15 s−1
|
55% and 75% narrow flow states |